LPAR1 antagonist effectively alleviates Rgs22 deficiency-induced ventricular enlargement. (IMAGE)

Science China Press

LPAR1 antagonist effectively alleviates Rgs22 deficiency-induced ventricular enlargement.

Caption

The representative MRI images of coronal sections, transverse sections and sagittal sections of Rgs22−/− rats before (left) or after (right) AM095 or LPAR2 antagonist treatment. Compared to the control group (LPAR2 antagonist treatment), the AM095-treated rats exhibited significant reduction in ventricular dilation. Photo credit: Xue Pang and Lin Gu.

Credit

Photo credit: Xue Pang and Lin Gu.

Usage Restrictions

Use with credit.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.